Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Automation
Return to: PBR Home | Automation
Today in Automation

Automation

GSK, Cold Spring Harbor Lab to develop new drugs for obesity and diabetes US-based Cold Spring Harbor Laboratory has entered into partnership with British pharmaceutical firm GlaxoSmithKline (GSK) to develop new treatments for obesity and type 2 diabetes. Automation > IT & Software > News

Latest Automation News by Sector

Select a sector from the list or browse by sector below:

IT & Software

Dicerna gets FDA orphan drug status for DCR-PH1 to treat primary hyperoxaluria type 1
By PBR Staff Writer
Dicerna Pharmaceuticals has received orphan drug designation from the US Food and Drug Administration (FDA) for its therapeutic candidate, DCR-PH1, to treat primary hyperoxaluria type 1 (PH1), a severe, rare, inherited disorder of the liver.
News
Oasmia's Paclical cancer drug gets Russian marketing approval
By PBR Staff Writer
Sweden-based Oasmia Pharmaceutical has received market authorization from the Russian Ministry of Health for its lead cancer product Paclical in Russia.
News

Laboratory Instrumentation

Cepheid, pharma firms collaborate on diagnostic test for multidrug-resistant bacterial infections
By PBR Staff Writer
Cepheid has entered into a new collaboration with AstraZeneca, Cubist and GSK to encourage transformational change in infectious disease therapy.
News
BioLight announces start of clinical study with DiagnosTear dry eye syndrome diagnostic assay
BioLight Life Sciences Investments announced that DiagnosTear has received all necessary approvals from Sheba Medical Center near Tel Aviv to begin a clinical study with its TeaRx, point-of-care Dry Eye Syndrome diagnostic assay. DiagnosTear is part of BioLight’s XLVision Sciences ophthalmology cluster.
News